Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001088875-24-000098
Filing Date
2024-10-09
Accepted
2024-10-09 10:20:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5407
  Complete submission text file 0001088875-24-000098.txt   7043
Mailing Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN
Business Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN 00441312752000
BAILLIE GIFFORD & CO (Filed by) CIK: 0001088875 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SCHEDULE 13G/A

Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Subject) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91923 | Film No.: 241361735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)